Showing 401-410 of 7110 results for "".
Journal Club: AD's Impact on Mental Health
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-ads-impact-mental-health/28628/Practical Dermatology Editorial Board member Peter Lio, MD, chats with dermatologist Robert Sidbury, MD, MPH, about the Cureus article, "Investigation of the Impact of Atopic Dermatitis (AD) on Stress, Depression, Anxiety, and Suicidal Ideation: A Systematic Review and Meta-Analysis."Revenue Cycle Management: What Physicians and Administrators Need to Know
https://practicaldermatology.com/topics/practice-management/revenue-cycle-management-what-physicians-and-administrators-need-to-know/23536/The latest generation of RCM software can benefit practices in multiple ways.A Closer Look at Cibinqo for AD Management
https://practicaldermatology.com/topics/atopic-dermatitis/a-closer-look-at-cibinqo-for-ad-management/23664/Oral JAK inhibitors offer rapid onset of efficacy and some flexibility in the management of moderate to severe eczema.At-home Medical Aesthetic Devices: What Your Patients Should Be Aware Of
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/at-home-medical-aesthetic-devices-what-your-patients-should-be-aware-of/23149/Despite some reputable standouts, most consumer-grade medical aesthetic devices are manufactured overseas and sold online and tend to be of somewhat suspect quality.Neal Bhatia, MD
https://practicaldermatology.com/topics/practice-management/neal-bhatia-md/22950/Dr. Neal Bhatia is an Associate Professor of Dermatology at Harbor UCLA and is also in private practice in Long Beach, CA. He has published articles on a wide range of topics covering both medical and cosmetic dermatology, and he completed a oneyear appointment on the AAD Board of Directors. Ahead,Journal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-oral-jak-inhibitors-moderate-severe-ad/24539/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and ImmunolMultiple Eruptive Myxoid Dermatofibromas in Patient With History of HIV
https://practicaldermatology.com/topics/skin-of-color/multiple-eruptive-myxoid-dermatofibromas-in-patient-with-history-of-hiv/24216/Multiple eruptive dermatofibromas, a rare presentation of dermatofibroma, has been associated with altered immunity such as HIV/AIDS.Thick Melanomas: Assessing Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thick-melanomas-assessing-prognosis/23685/New data identifies stratified risk based on the thickness of melanomas thicker than 4mm.Molluscum: Challenges and a Promising Solution
https://practicaldermatology.com/topics/rare-disease/molluscum-challenges-and-a-promising-solution/23532/Molluscum is under-diagnosed and under-treated in the US, but a new treatment could change that.The Microbiome and Its Impact on Antibiotic Use in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-microbiome-and-its-impact-on-antibiotic-use-in-dermatology/23278/Despite focus on the clinical consequences of overusing antibiotics for decades, relatively little has been said about the potential impact on the microbiome.